Savvywire
Payments companies reported to CMS as associated with Savvywire. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Savvywire, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Savvywire
These are the largest totals companies reported as associated with Savvywire. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Philippe Genereux | New York, NY | Cardiovascular Disease | $396,783.49 |
| Ruby Satpathy | Jacksonville, FL | Interventional Cardiology | $48,263.06 |
| Ronald Caputo | Naples, FL | Cardiovascular Disease | $44,088.87 |
| Ravi Ramana | Palos Park, IL | Interventional Cardiology | $43,180.88 |
| Khaled Khalaf | Humble, TX | Interventional Cardiology | $31,730.82 |
| Nouri Al Khaled | Evergreen Park, IL | Cardiovascular Disease | $22,500.00 |
| Rahul Sharma | Stanford, CA | Interventional Cardiology | $22,337.22 |
| Roberto Cubeddu | Naples, FL | Interventional Cardiology | $14,768.21 |
| Vijay Iyer | Amherst, NY | Cardiovascular Disease | $14,233.23 |
| Joseph Degregorio | Glen Ridge, NJ | Cardiovascular Disease | $12,171.66 |
Prescribed Savvywire?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.